US 12,258,589 B2
Glycated hemoglobin oxidase variant and method for measurement
Atsushi Ichiyanagi, Chiba (JP)
Assigned to Kikkoman Corporation, Chiba (JP)
Appl. No. 16/643,358
Filed by Kikkoman Corporation, Noda (JP)
PCT Filed Aug. 31, 2018, PCT No. PCT/JP2018/032389
§ 371(c)(1), (2) Date Feb. 28, 2020,
PCT Pub. No. WO2019/045052, PCT Pub. Date Mar. 7, 2019.
Claims priority of application No. 2017-167890 (JP), filed on Aug. 31, 2017.
Prior Publication US 2020/0283741 A1, Sep. 10, 2020
Int. Cl. C12N 9/02 (2006.01); C12Q 1/26 (2006.01)
CPC C12N 9/0083 (2013.01) [C12Q 1/26 (2013.01); C12Y 114/99003 (2013.01)] 3 Claims
OG exemplary drawing
 
1. A method for measurement of HbS1c or HbC1c in a sample comprising a step of allowing glycated hemoglobin oxidase to act on a sample that contains HbS1c or HbC1c, and a step of measuring the HbS1c or HbC1c, wherein protease is not added to the sample.